GSB-2022
Scientific Program

 

Plenary Forum

Day 1: Morning, May 11, 2022

Moderator

Dr. John Xu, SVP, Abpro, USA

Time

Speeches and Speakers

09:30-09:35

Moderator’s Introduction

09:35-10:00

 

Title: TBD
Dr. H. Michael Shepard,
President and CEO, Enosi Life Sciences, USA
2019 Lasker Awards


10:00-10:25

 
Title: How Spearheading Cell & Gene Therapy Changes Our Innovation Model in Pharma

Dr. Wolfram Carius, Executive Vice President of Cell and Gene Therapy, Bayer Pharmaceuticals, Germany 

 

10:25-10:50

 

Title: Cell-penetrating Peptides and Drug Delivery
Dr. Ulo Langel, Professor, Stockholm University, Sweden
Member of the Academia Europaea; Foreign Member of Estonian Academy of Science


10:50-11:15

 

Title: R & D of Broad-spectral Antivirals
Dr. Shibo Jiang, Director, Institute of Medical Microbiology, Fudan University, China


11:15-11:45

 

Title: TBD
Dr. Frank Li, Founder and CEO, BLA Regulatory, USA

 

11:45-12:10

Speech Opportunity Available

 

© 2003-2022 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799606, Fax: 0086-411-84796897